UBS Group’s Myovant Sciences Ltd. MYOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q1
Sell
-411,137
Closed -$11.1M 9896
2022
Q4
$11.1M Buy
411,137
+382,529
+1,337% +$10.3M ﹤0.01% 1325
2022
Q3
$515K Sell
28,608
-55,460
-66% -$998K ﹤0.01% 3345
2022
Q2
$1.04M Sell
84,068
-67,713
-45% -$841K ﹤0.01% 2861
2022
Q1
$2.02M Sell
151,781
-82,947
-35% -$1.11M ﹤0.01% 2643
2021
Q4
$3.66M Buy
234,728
+98,190
+72% +$1.53M ﹤0.01% 2392
2021
Q3
$3.06M Buy
136,538
+64,689
+90% +$1.45M ﹤0.01% 2426
2021
Q2
$1.64M Sell
71,849
-48,614
-40% -$1.11M ﹤0.01% 2885
2021
Q1
$2.48M Sell
120,463
-101,953
-46% -$2.1M ﹤0.01% 2576
2020
Q4
$6.14M Buy
222,416
+120,752
+119% +$3.34M ﹤0.01% 1696
2020
Q3
$1.43M Buy
101,664
+86,778
+583% +$1.22M ﹤0.01% 2689
2020
Q2
$307K Buy
14,886
+10,449
+235% +$215K ﹤0.01% 3722
2020
Q1
$34K Sell
4,437
-7,598
-63% -$58.2K ﹤0.01% 5236
2019
Q4
$187K Buy
12,035
+4,885
+68% +$75.9K ﹤0.01% 4643
2019
Q3
$37K Buy
7,150
+6,608
+1,219% +$34.2K ﹤0.01% 5419
2019
Q2
$5K Sell
542
-650
-55% -$6K ﹤0.01% 6527
2019
Q1
$28K Sell
1,192
-246
-17% -$5.78K ﹤0.01% 5192
2018
Q4
$23K Buy
1,438
+146
+11% +$2.34K ﹤0.01% 5760
2018
Q3
$34K Buy
+1,292
New +$34K ﹤0.01% 5550
2018
Q2
Sell
-1,025
Closed -$22K 7228
2018
Q1
$22K Buy
+1,025
New +$22K ﹤0.01% 5493
2017
Q4
Sell
-1,184
Closed -$18K 7047
2017
Q3
$18K Buy
1,184
+1,069
+930% +$16.3K ﹤0.01% 5638
2017
Q2
$1K Sell
115
-1,628
-93% -$14.2K ﹤0.01% 6585
2017
Q1
$20K Sell
1,743
-1,282
-42% -$14.7K ﹤0.01% 5232
2016
Q4
$38K Buy
+3,025
New +$38K ﹤0.01% 5126